New Brunswick confirms its first blood clot death linked to AstraZeneca vaccine

 FREDERICTON, N.B. - A New Brunswick resident in their 60s has died after developing blood clots after receiving the Oxford-AstraZeneca vaccine. 

They are the first person to die in New Brunswick from a vaccine-related cause.

The person received the AstraZeneca vaccine in mid-April and developed symptoms seven days later, a May 5 release from the province said.

They went to an emergency room for treatment and died two days later in hospital.

It is the second serious case of adverse effects from the vaccine, Dr. Jennifer Russell, the province's chief medical officer of health, said in the release.

However, Russell stressed that vaccine-related side effects, including low platelets and blood clots, continue to be rare.

“I offer my sincere condolences to the bereaved family and friends,” said Russell.

“Out of the hundreds of thousands of doses of AstraZeneca vaccine administered as part of the country’s massive vaccination campaign, there will be rare cases where thrombosis will occur. However, the risks remain minimal compared to the risks, complications and potential consequences of COVID-19.”

Public Health reminded New Brunswickers to seek immediate medical attention after receiving the AstraZeneca or Covishield vaccine if the following symptoms develop between four and 28 days after vaccination:

• shortness of breath;
• chest pain;
• leg swelling;
• persistent abdominal pain;
• neurological symptoms, such as severe and persistent worsening headaches or blurred vision; or
• skin bruising or tiny blood spots under the skin beyond the site of the injection

Alberta reported Tuesday that a woman in her 50s died after experiencing the rare blood clot condition after receiving the AstraZeneca vaccine. 

Its the second case of blood clots and the first death of a patient after more than 253,000 doses of AstraZeneca were administered in the province, Alberta's chief medical officer of health Dr. Deena Hinshaw said in a statement.

"While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine," Hinshaw said.

Last month, Quebec reported Canada's first death of a patient who received the AstraZeneca COVID-19 vaccine.   Source

 https://www.castanet.net/news/Canada/332985/Alberta-and-New-Brunswick-confirm-blood-clot

 https://www.cbc.ca/news/canada/new-brunswick/covid-19-pandemic-cases-1.6014323

 https://www.theglobeandmail.com/canada/article-new-brunswick-reports-provinces-first-death-from-

Related  Fewer Than 1% of Vaccine Injuries gets Reported to VAERS